377 related articles for article (PubMed ID: 7548714)
1. Design and analysis of group sequential logrank tests in maximum duration versus information trials.
Kim K; Boucher H; Tsiatis AA
Biometrics; 1995 Sep; 51(3):988-1000. PubMed ID: 7548714
[TBL] [Abstract][Full Text] [Related]
2. Implementation of group sequential logrank tests in a maximum duration trial.
Lan KK; Lachin JM
Biometrics; 1990 Sep; 46(3):759-70. PubMed ID: 2242413
[TBL] [Abstract][Full Text] [Related]
3. Use of logrank tests and group sequential methods at fixed calendar times.
DeMets DL; Gail MH
Biometrics; 1985 Dec; 41(4):1039-44. PubMed ID: 4096915
[TBL] [Abstract][Full Text] [Related]
4. Implementing type I & type II error spending for two-sided group sequential designs.
Rudser KD; Emerson SS
Contemp Clin Trials; 2008 May; 29(3):351-8. PubMed ID: 17933592
[TBL] [Abstract][Full Text] [Related]
5. Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit.
Lachin JM
Clin Trials; 2009 Dec; 6(6):565-73. PubMed ID: 19933716
[TBL] [Abstract][Full Text] [Related]
6. A group-sequential design for clinical trials with treatment selection.
Stallard N; Friede T
Stat Med; 2008 Dec; 27(29):6209-27. PubMed ID: 18792085
[TBL] [Abstract][Full Text] [Related]
7. Exact permutational tests for group sequential clinical trials.
Mehta CR; Patel N; Senchaudhuri P; Tsiatis A
Biometrics; 1994 Dec; 50(4):1042-53. PubMed ID: 7786986
[TBL] [Abstract][Full Text] [Related]
8. Clinical trial designs based on sequential conditional probability ratio tests and reverse stochastic curtailing.
Tan M; Xiong X; Kutner MH
Biometrics; 1998 Jun; 54(2):682-95. PubMed ID: 9629648
[TBL] [Abstract][Full Text] [Related]
9. Study duration for clinical trials with survival response and early stopping rule.
Kim K; Tsiatis AA
Biometrics; 1990 Mar; 46(1):81-92. PubMed ID: 2350572
[TBL] [Abstract][Full Text] [Related]
10. Sequential analysis of censored survival data from three treatment groups.
Betensky RA
Biometrics; 1997 Sep; 53(3):807-22. PubMed ID: 9333347
[TBL] [Abstract][Full Text] [Related]
11. A review of methods for futility stopping based on conditional power.
Lachin JM
Stat Med; 2005 Sep; 24(18):2747-64. PubMed ID: 16134130
[TBL] [Abstract][Full Text] [Related]
12. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
Lewis RJ; Lipsky AM; Berry DA
Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
[TBL] [Abstract][Full Text] [Related]
13. Early stopping to accept H(o) based on conditional power: approximations and comparisons.
Betensky RA
Biometrics; 1997 Sep; 53(3):794-806. PubMed ID: 9290216
[TBL] [Abstract][Full Text] [Related]
14. A note on P-values under group sequential testing and nonproportional hazards.
Gillen DL; Emerson SS
Biometrics; 2005 Jun; 61(2):546-51. PubMed ID: 16011703
[TBL] [Abstract][Full Text] [Related]
15. Group sequential design for comparative diagnostic accuracy studies.
Mazumdar M; Liu A
Stat Med; 2003 Mar; 22(5):727-39. PubMed ID: 12587102
[TBL] [Abstract][Full Text] [Related]
16. Designing complex group sequential survival trials.
Lakatos E
Stat Med; 2002 Jul; 21(14):1969-89. PubMed ID: 12111882
[TBL] [Abstract][Full Text] [Related]
17. Changing frequency of interim analysis in sequential monitoring.
Lan KK; DeMets DL
Biometrics; 1989 Sep; 45(3):1017-20. PubMed ID: 2790114
[TBL] [Abstract][Full Text] [Related]
18. Efficient group sequential designs when there are several effect sizes under consideration.
Jennison C; Turnbull BW
Stat Med; 2006 Mar; 25(6):917-32. PubMed ID: 16220524
[TBL] [Abstract][Full Text] [Related]
19. Construction of group sequential designs in clinical trials on the basis of detectable treatment differences.
Schäfer H; Müller HH
Stat Med; 2004 May; 23(9):1413-24. PubMed ID: 15116350
[TBL] [Abstract][Full Text] [Related]
20. A two-stage procedure for survival studies with surrogate endpoints.
Flandre P; O'Quigley J
Biometrics; 1995 Sep; 51(3):969-76. PubMed ID: 7548712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
